ArticleOncogene2017
EMP2 is a novel therapeutic target for endometrial cancer stem cells.
M H Kiyohara et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
27 papers cite it
this papercites it
ArticleOncogene2017
M H Kiyohara et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.